We are MHRA licensed to include commercial manufacture.
Quay Pharma has successfully updated its license with the MHRA to include commercial manufacture.
This expansion to Quay Pharma’s service offering now allows for development from late preclinical to commercial manufacture.
The application ran in conjunction with the expansion to the GMP manufacturing area.
Commercial Services Include:
SGS PACE (Product Accelerated Clinically Enabled) helps you bring the vision of your new drug to life - Faster.
Robust formulation development strategies tailored to the characteristics of each individual API.
Analysis of Active Pharmaceutical Ingredients (APIs), including those that present particular challenges.
Dosage form optimisation for a wide range of product types including those that have poor solubility or bioavailability.
Analytical specialists working alongside our formulation and manufacturing teams which provide expert advice.
Early clinical formulations and clinical manufacturing of First in Human trials and clinical evaluations of your API.
Fully equipped and accredited to manufacture a wide range of products for Phase II and small-scale Phase III trials.
MHRA licensed to include commercial manufacture. Services include contract packaging and assembly...
Over ten years of extensive development and manufacture experience converting controlled substances into a variety of different dosage forms.
Complete range of clinical trial supply packaging for solid and liquid dosages. Despatched with full QP release certification.
One of the few companies licensed for the clinical manufacture of live biotherapeutics products.
Perfectly equipped to deliver an Orphan Drug molecule from preclinical and formulation development to small scale commercialisation.
One of the limited number of contract manufacturers who hold an MRHA license for the manufacture and supply of ‘specials’.
Let's Talk Project Success
Talk directly to the Quay staff - Our dedicated team leaders are ready to listen and help with your project.